Unlocking the Potential of mRNA Cancer Vaccines

Following the COVID-19 pandemic, there has been a growing interest in developing mRNA vaccines and translating the knowledge learned into creating efficacious mRNA cancer vaccines. The evidence of this is shown by more than 130 active developers in the field today.

Explore the mRNA cancer vaccines’ unique components and characteristics by downloading our infographic.

mRNA Cancer Vaccine Infographic

The Infographic Includes:

  • A breakdown on the different types of cancer vaccines in the development pipeline
  • A review of the trial landscape, shedding light on trends in clinical growth over the years.
  • Analysis on the promising progress seen in 2 mRNA cancer vaccine phase 3 trials

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search